Clinical Trial to Investigate the Effects of Food on the Pharmacokinetics

See also
Status	Clinical Trial	Phase
Completed	`NCT00538798` - PET Imaging of Brain mGluR5 Receptors Using [18F]SP203	Phase 1
Recruiting	`NCT02575755` - A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG Women	Phase 4
Completed	`NCT05366283` - Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Sargramostim Administered Subcutaneously, Intravenously, or by Inhalation	Phase 1

See also

Status

Clinical Trial

Phase

Completed

NCT00538798 - PET Imaging of Brain mGluR5 Receptors Using [18F]SP203

Phase 1

Recruiting

NCT02575755 - A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG Women

Phase 4

Completed

NCT05366283 - Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Sargramostim Administered Subcutaneously, Intravenously, or by Inhalation

Phase 1

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06461078
Study type	Interventional
Source	Il-Yang Pharm. Co., Ltd.
Contact	Na Yun Kim
Phone	+82.70.7165.7316
Email	nykim@ilyang.co.kr
Status	Not yet recruiting
Phase	Phase 1
Start date	August 5, 2024
Completion date	June 30, 2025

Clinical Trial to Investigate the Effects of Food on the Pharmacokinetics and Safety of Orally Administered Radotinib

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms